Literature DB >> 3315142

Guam ALS/parkinsonism-dementia: a long-latency neurotoxic disorder caused by "slow toxin(s)" in food?

P S Spencer1.   

Abstract

Parkinsonism (P) with progressive dementia (D) of the Alzheimer type is recognized as a clinical variant of a form of amyotrophic lateral sclerosis (ALS) that has occurred in high incidence among the Chamorro people of the islands of Guam and Rota in the Marianas chain of Micronesia. The declining annual incidence, upward shifting of the age of onset, narrowing of the sex ratio, and occurrence of the disease among non-Chamorros, point to a disappearing environmental causation peculiar to the traditional culture of these islands. Evidence is presented in support of the proposal that heavy use of certain toxic plants, notably cycads, a traditional source of food and medicine for the Chamorro people, plays an important etiological role. Clinical and epidemiological approaches are offered to test for a relationship between ALS/P-D and long-latency plant toxicity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3315142     DOI: 10.1017/s0317167100037732

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  24 in total

Review 1.  Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Peter W French; Russell Ludowyke; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2018-12-05       Impact factor: 3.911

2.  A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents.

Authors:  L G Gunnarsson; L Bodin; B Söderfeldt; O Axelson
Journal:  Br J Ind Med       Date:  1992-11

Review 3.  Motor neuron disease: etiology, pathogenesis and treatment--a review.

Authors:  D J Donohoe; B Brady
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

Review 4.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

5.  Neurological clues from environmental neurotoxins.

Authors:  C N Martyn
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-08

Review 6.  Minireview: liver X receptor beta: emerging roles in physiology and diseases.

Authors:  Chiara Gabbi; Margaret Warner; Jan-Ake Gustafsson
Journal:  Mol Endocrinol       Date:  2008-12-12

7.  An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis.

Authors:  L Mazzini; D Testa; C Balzarini; G Mora
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

8.  1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis.

Authors:  Hélène Blasco; Philippe Corcia; Caroline Moreau; Ségolène Veau; Clémentine Fournier; Patrick Vourc'h; Patrick Emond; Paul Gordon; Pierre-François Pradat; Julien Praline; David Devos; Lydie Nadal-Desbarats; Christian R Andres
Journal:  PLoS One       Date:  2010-10-08       Impact factor: 3.240

9.  Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.

Authors:  V Buée-Scherrer; L Buée; P R Hof; B Leveugle; C Gilles; A J Loerzel; D P Perl; A Delacourte
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

10.  A pilot trial of dextromethorphan in amyotrophic lateral sclerosis.

Authors:  H Askmark; S M Aquilonius; P G Gillberg; L J Liedholm; E Stålberg; R Wuopio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.